(Q54606960)

English

A phase I/IIa clinical trial of a recombinant Rho protein antagonist in acute spinal cord injury.

scientific article

Statements

A phase I/IIa clinical trial of a recombinant Rho protein antagonist in acute spinal cord injury. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit